Cetirizine, Pseudoephedrine Articles
US FDA clears J&J's non-Rx Zyrtec
19 November 2007
Profits on the increase at Belgium's UCB Group
15 April 2002
UCB to post 20% profit growth in 2001
12 December 2001
Pfizer's Zyrtec-D 12-Hour approved in USA
16 August 2001
Update: UCB 1st-half pharma turnover leaps 31%
31 July 2001
UCB 1st-half pharma sales leap 31%
30 July 2001
UCB 1st-half pharma sales leap 31%
27 July 2001
Good start to 2001 for UCB pharma
15 June 2001
UCB reports 27% growth in pretax profit
31 July 2000
Showing 1-9 of 9 articles
- 1
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- US FDA advisory panel backs approval of Merck & Co's suvorexant, but only at lower doses
- Italy's pharma market slump set to continue, warns GlobalData
- Is failure to adopt business process management putting the pharma industry at risk?
